|Up a level|
Brunner, Stefan and Schichl, Gabriela and Kesselring, Rebecca and Martin, Maria and Balam, Saido and Schlitt, Hans-Jürgen and Geissler, Edward K. and Fichtner-Feigl, Stefan (2013) IL-13 signaling via IL-13Ralpha2 triggers TGF-beta1-dependent allograft fibrosis. Transplantation Research 2, p. 16.
Riquelme, Paloma and Geissler, Edward K. and Hutchinson, James A. (2012) Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs. Transplantation Research 1, p. 17.
Dillmann, Johannes and Popp, Felix C. and Fillenberg, Barbara and Zeman, Florian and Eggenhofer, Elke and Farkas, Stefan and Scherer, Marcus N. and Koller, Michael and Geissler, Edward K. and Deans, Robert and Ladenheim, Deborah and Loss, Martin and Schlitt, Hans-Jürgen and Dahlke, Marc H. (2012) Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation. Trials 13, p. 211.
Werner, Jens M and Busl, Elisabeth and Farkas, Stefan A. and Schlitt, Hans J. and Geissler, Edward K. and Hornung, Matthias (2011) DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice. BMC immunology 12, p. 26.
Popp, Felix C. and Fillenberg, Barbara and Eggenhofer, Elke and Renner, Philipp and Dillmann, Johannes and Benseler, Volker and Schnitzbauer, Andreas A. and Hutchinson, James and Deans, Robert and Ladenheim, Deborah and Graveen, Cheryl A and Zeman, Florian and Koller, Michael and Hoogduijn, Martin J and Geissler, Edward K. and Schlitt, Hans J. and Dahlke, Marc H. (2011) Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation - a phase I study (MISOT-I). Journal of translational medicine 9 (1), p. 124.
Hackl, Christina and Lang, Sven A. and Moser, Christian and Mori, Akira and Fichtner-Feigl, Stefan and Hellerbrand, Claus and Dietmeier, Wolfgang and Schlitt, Hans J. and Geissler, Edward K. and Stoeltzing, Oliver (2010) Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. BMC cancer 10, p. 668.
Koehl, Gudrun E. and Geissler, Edward K. and Iacobelli, Massimo and Frei, Caroline and Burger, Verena and Haffner, Silvia and Holler, Ernst and Andreesen, Reinhard and Schlitt, Hans J. and Eissner, Günther (2007) Defibrotide: an endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo. Cancer biology & therapy 6 (5), pp. 686-90.
Hornung, Matthias and Farkas, Stefan A. and Sattler, Christine and Schlitt, Hans J. and Geissler, Edward K. (2006) DX5+ NKT cells induce the death of colitis-associated cells: involvement of programmed death ligand-1. European journal of immunology 36 (5), pp. 1210-1221.
Farkas, Stefan and Hornung, Matthias and Sattler, Christine and Edtinger, Karoline and Steinbauer, Markus and Anthuber, Matthias and Schlitt, Hans J. and Herfarth, Hans and Geissler, Edward K. (2006) Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis. International journal of colorectal disease 21 (1), pp. 71-78.
Geissler, Edward K. and Wang, Jue and Fechner, John H. and Burlingham, William J. and Knechtle, Stuart J. (1994) Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. The Journal of Immunology 152 (2), pp. 413-421.
Knechtle, Stuart J. and Wang, Jue and Jiao, Shoushu and Geissler, Edward K. and Sumimoto, Ryo and Wolff, Jon (1994) Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation® 57 (7), pp. 990-996.
Wang, Jue and Geissler, Edward K. and Fechner, John H. and Burlingham, William J. and Knechtle, Stuart J. (1994) Use of donor serum to prevent passive transfer of hyperacute rejection. Journal of surgical research 57 (1), pp. 150-155.